|
US2010260734A1
|
|
Method of stimulating prosaposin receptor activity
|
|
AU2758102A
|
|
Prosaposin and cytokine-derived peptides as therapeutic agents
|
|
US7109168B1
|
|
Retro-inverso peptides derived from leukemia inhibitory factor
|
|
IL147094D0
|
|
Retro-inverso peptides derived from interleukin-6
|
|
US7115571B1
|
|
Retro-inverso peptides derived from interleukin-3
|
|
IL147093D0
|
|
Retro-inverso peptides derived from interleukin-3
|
|
IL147095D0
|
|
Retro-inverso peptides derived from leukemia inhibitory factor
|
|
US7135461B1
|
|
Retro-inverso peptides derived from interleukin-6
|
|
EP1165611A1
|
|
Retro-inverso prosaposin-derived peptides and use thereof
|
|
WO0014113A2
|
|
Method of stimulating prosaposin receptor activity
|
|
CN1324251A
|
|
Method of stimulating prosaposin receptor activity
|
|
WO0012553A1
|
|
Cyclic prosaposin-derived peptides and uses thereof
|
|
US6458357B1
|
|
Retro-inverso neurotrophic and analgesic peptides
|
|
EP0996856A1
|
|
Prosaposin receptor assay
|
|
EP0971956A2
|
|
Synthetic saposin c-derived neurotrophic peptides
|
|
US5571787A
|
|
Prosaposin as a neurotrophic factor
|
